Ebru Bodur
Impact in
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Pharmacology 18
- Cholinesterase and Neurodegenerative Diseases 17
-
- Computational Drug Discovery Methods 16
- Co-authors
- Turgay Dalkara (4 shared papers)Yasemin Özdemir (3 shared papers)Müge Yemişçi (4 shared papers)Yılmaz Çapan (2 shared papers)Seçil Çaban (2 shared papers)Ömer Faruk Türkoğlu (8 shared papers)Hakan Eroğlu (6 shared papers)Hülya Karataş (2 shared papers)
- Journals
- The Protein Journal (5 papers)Chemico-Biological Interactions (5 papers)Biochimie (3 papers)Journal of Neurochemistry (2 papers)Journal of Endocrinology (1 paper)
- Partner nations
- TürkiyeUnited StatesItaly
In The Last Decade
Ebru Bodur
37 papers receiving 578 citations
Peers
Comparison fields: 5 of 84
- Pharmaceutical Science 56
- Biomaterials 115
- Pharmacology 131
- Neurology 56
- Developmental Neuroscience 26
Countries citing papers authored by Ebru Bodur
This map shows the geographic impact of Ebru Bodur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Bodur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Bodur more than expected).
Fields of papers citing papers by Ebru Bodur
This network shows the impact of papers produced by Ebru Bodur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Bodur. The network helps show where Ebru Bodur may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebru Bodur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 144 | |
| 2 | 2011 | 40 | |
| 3 | 2012 | 29 | |
| 4 | 2012 | 25 | |
| 5 | 2008 | 25 | |
| 6 | 2020 | 21 | |
| 7 | 2001 | 20 | |
| 8 | 2023 | 20 | |
| 9 | 2007 | 18 | |
| 10 | 2005 | 17 | |
| 11 | 2016 | 16 | |
| 12 | 2003 | 16 | |
| 13 | 2010 | 15 | |
| 14 | 2022 | 14 | |
| 15 | 2022 | 14 | |
| 16 | 2010 | 14 | |
| 17 | 2012 | 14 | |
| 18 | 2010 | 13 | |
| 19 | 2016 | 13 | |
| 20 | 2023 | 12 |
About Ebru Bodur
Ebru Bodur is a scholar working on Pharmacology, Computational Theory and Mathematics, Plant Science, Molecular Biology and Neurology, having authored 38 papers that have together received 589 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (17 papers), Computational Drug Discovery Methods (16 papers), Pesticide Exposure and Toxicity (9 papers), Biochemical Acid Research Studies (4 papers), Medicinal Plants and Neuroprotection (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). The work is most often cited by research in Pharmaceutical Science (56 citations), Biomaterials (115 citations), Pharmacology (131 citations), Neurology (56 citations) and Developmental Neuroscience (26 citations). Ebru Bodur has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Turgay Dalkara, Yasemin Özdemir, Müge Yemişçi, Yılmaz Çapan, Seçil Çaban, Ömer Faruk Türkoğlu, Hakan Eroğlu, Hülya Karataş, Levent Öner and Mustafa F. Sargon. Their work appears in journals such as The Protein Journal, Chemico-Biological Interactions, Biochimie, Journal of Neurochemistry and Journal of Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.